UBS Group AG - CHINA SXT PHARMACEUTICALS IN ownership

CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$18,000
-45.5%
55,184
-59.5%
0.00%
Q3 2020$33,000
-50.0%
136,125
+9.1%
0.00%
Q2 2020$66,000
+500.0%
124,770
+523.8%
0.00%
Q1 2020$11,00020,000
+199900.0%
0.00%
Q4 2019$0
-100.0%
10
-99.5%
0.00%
Q2 2019$7,000
-53.3%
1,971
-10.9%
0.00%
Q1 2019$15,0002,2110.00%
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Hudock, Inc. 7,500$2,0000.00%
UBS Group AG 55,184$18,0000.00%
FIFTH THIRD BANCORP 1,000$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 106,568$35,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 36,886$12,0000.00%
Renaissance Technologies 664,647$218,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders